X0202 4 2008-05-15 1 0001027362 SYNPLICITY INC SYNP 0001327289 Dauman Andrew C/O SYNPLICITY, INC. 600 WEST CALIFORNIA AVE. SUNNYVALE CA 94086 0 1 0 0 Sr VP, Worldwide Engineering Common Stock 2008-05-15 2008-05-15 4 D 0 45643 D 0 D Stock Option (Right to Buy) 3.75 1999-12-31 1999-12-31 4 D 0 21333 0 D 2009-12-31 Common Stock 21333 0 D Stock Option (Right to Buy) 5.10 2000-01-31 2000-01-31 4 D 0 13333 0 D 2010-01-31 Common Stock 13333 0 D Stock Option (Right to Buy) 2.25 1999-07-30 1999-07-30 4 D 0 16666 0 D 2009-07-30 Common Stock 16666 0 D Stock Option (Right to Buy) 10.45 2000-09-06 2000-09-06 4 D 0 30000 0 D 2010-09-06 Common Stock 30000 0 D Stock Option (Right to Buy) 4.89 2004-08-30 2004-08-30 4 D 0 25000 0 D 2014-08-30 Common Stock 25000 0 D Stock Option (Right to Buy) 5.75 2005-07-19 2005-07-19 4 D 0 14300 0 D 2015-07-19 Common Stock 14300 0 D Stock Option (Right to Buy) 6.52 2007-08-20 2007-08-20 4 D 0 40000 0 D 2017-08-20 Common Stock 40000 0 D Stock Option (Right to Buy) 9.00 2002-01-22 2002-01-22 4 D 0 4430 0 D 2012-01-22 Common Stock 4430 0 D Stock Option (Right to Buy) 4.58 2002-06-28 2002-06-28 4 D 0 25000 0 D 2012-06-28 Common Stock 25000 0 D Stock Option (Right to Buy) 5.31 2003-06-24 2003-06-24 4 D 0 25000 0 D 2013-06-24 Common Stock 25000 0 D Stock Option (Right to Buy) 5.96 2005-05-18 2005-05-18 4 D 0 80000 0 D 2015-05-18 Common Stock 80000 0 D Stock Option (Right to Buy) 4.58 2002-06-28 2002-06-28 4 D 0 44000 0 D 2012-06-28 Common Stock 44000 0 D Stock Option (Right to Buy) 5.48 2006-07-21 2006-07-21 4 D 0 15000 0 D 2016-07-21 Common Stock 15000 0 D Stock Option (Right to Buy) 7.99 2008-05-14 2008-05-14 4 D 0 25000 0 D 2015-05-14 Common Stock 25000 0 D Restricted Stock Unit 7.99 2008-05-14 2008-05-14 4 D 0 7500 0 D 2015-05-14 Common Stock 7500 0 D Includes 1,000 shares acquired on April 29, 2008 and 310 shares acquired on May 14, 2008 through the issuer's Employee Stock Purchase Plan. Disposed of pursuant to amerger agreement between the issuer, Synopsys, Inc. ("Synopsys") and St. Andrews Acquisition Corp. (the "Merger") in exchange for merger consideration of $8.00 per share as provided in the merger agreement. This option provided for vesting over 4 years. Pursuant to the terms of the Merger, this option was not assumed by Synopsys, and Reporting Person was paid an amount equal to $4.25 per share and the option was cancelled. This option provided for vesting over 4 years. Pursuant to the terms of the Merger, this option was not assumed by Synopsys, and Reporting Person was paid an amount equal to $2.90 per share and the option was cancelled. This option provided for vesting over 4 years. Pursuant to the terms of the Merger, this option was not assumed by Synopsys, and Reporting Person was paid an amount equal to $5.75 per share and the option was cancelled. This option provided for vesting over 4 years. Pursuant to the terms of the Merger, this option was not assumed by Synopsys, and the option was cancelled. This option provided for vesting over 4 years. Upon effectiveness of the Merger, this option was exchanged for an option to purchase 8,479 shares of Synopsys Common Stock with an exercise price of $14.42 per share. This option provided for vesting over 4 years. Upon effectiveness of the Merger, this option was exchanged for an option to purchase 4,850 shares of Synopsys Common Stock with an exercise price of $16.96 per share. This option provided for vesting over 4 years. Upon effectiveness of the Merger, this option was exchanged for an option to purchase 13,567 shares of Synopsys Common Stock with an exercise price of $19.23 per share. This option provided for vesting over 4 years. Upon effectiveness of the Merger, this option was exchanged for an option to purchase 1,502 shares of Synopsys Common Stock with an exercise price of $26.54 per share. This option provided for vesting over 4 years. Upon effectiveness of the Merger, this option was exchanged for an option to purchase 8,479 shares of Synopsys Common Stock with an exercise price of $13.51 per share. This option provided for vesting over 4 years. Upon effectiveness of the Merger, this option was exchanged for an option to purchase 8,479 shares of Synopsys Common Stock with an exercise price of $15.66 per share. This option provided for vesting over 4 years. Upon effectiveness of the Merger, this option was exchanged for an option to purchase 27,134 shares of Synopsys Common Stock with an exercise price of $17.58 per share. This option provided for vesting over 4 years. Upon effectiveness of the Merger, this option was exchanged for an option to purchase 14,924 shares of Synopsys Common Stock with an exercise price of $13.51 per share. This option provided for vesting over 4 years. Upon effectiveness of the Merger, this option was exchanged for an option to purchase 5,087 shares of Synopsys Common Stock with an exercise price of $16.16 per share. This option provided for vesting over 4 years. Upon effectiveness of the Merger, this option was exchanged for an option to purchase 8,479 shares of Synopsys Common Stock with an exercise price of $23.55 per share. This restricted stock unit provided for vesting over 4 years. Upon effectiveness of the Merger, this restricted stock unit was exchanged for a restricted stock unit to purchase 2,543 shares of Synopsys Common Stock with an exercise price of $23.56 per share. John J. Hanlon, Atty-in-Fact for Andrew R. Dauman 2008-05-15